MedPath

Cognitive and Brain Development in Adolescents With Gilles de la Tourette Syndrome

Not Applicable
Conditions
Tourette Syndrome in Adolescence
Interventions
Behavioral: Behavioral testing on cognitive computerized tasks
Other: brain MRI
Other: TMS
Registration Number
NCT04179435
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Brief Summary

In children with neurodevelopmental disorders, adolescence is usually associated with a reshaping of the clinical picture and symptomatology. Tourette syndrome (TS) is a paradigmal neurodevelopmental syndrome characterised by involuntary paroxysmal movements (motor tics) and vocalisation (vocal tics) often associated with various psychiatric disorders. The neuronal and cognitive mechanisms associated with TS symptoms improvement during adolescence, or the persistence in adulthood remains unknown, and this is what we aim to address in this study.

Detailed Description

Thus, the aims of the present project is threefold:

Aim 1: To evaluate the maturation of cognitive functions in adolescents with TS compared to typically developing adolescents.

To achieve this aim, three distinct cognitive dimensions will be assessed in all subjects (patients and controls): (i) reward sensitivity and habit formation; (ii) cognitive impulsivity and action control and (iii) self-agency.

Aim 2: To identify neuronal correlates of cognitive function and brain development in health and disease. To achieve this aim, we will use a combined behavioural (as described in Aim 1), (i) neuroimaging and (ii) TMS approaches.

Aim 3: To predict clinical outcome . In this part of the project we aim to identify behavioural, imaging or neurophysiological markers of clinical outcome in patients with TS.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
132
Inclusion Criteria
  • Tourette syndrome
  • Ages 13 - 18
  • Acceptance to perform the Brain MRI
  • Acceptance to perform the cognitive testing
  • Acceptance to perform the TMS measures
Exclusion Criteria
  • Learning disability
  • Incompatibility with MRI procedure (metal body implants, pregnancy)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Tourette syndromebrain MRIPatients with Tourette syndrome aged 13 - 18 y.o. Interventions : Brain scans, cognitive testing, TMS measures
Tourette syndromeTMSPatients with Tourette syndrome aged 13 - 18 y.o. Interventions : Brain scans, cognitive testing, TMS measures
Tourette syndromeBehavioral testing on cognitive computerized tasksPatients with Tourette syndrome aged 13 - 18 y.o. Interventions : Brain scans, cognitive testing, TMS measures
Controlsbrain MRIControls matched to Tourette syndrome group nterventions : Brain scans, cognitive testing, TMS measures
ControlsTMSControls matched to Tourette syndrome group nterventions : Brain scans, cognitive testing, TMS measures
ControlsBehavioral testing on cognitive computerized tasksControls matched to Tourette syndrome group nterventions : Brain scans, cognitive testing, TMS measures
Primary Outcome Measures
NameTimeMethod
Behavioral test main outcome measures [4]from 16 to 20 months

agency composite scores

Behavioral test main outcome measures [2]from 16 to 20 months

discounting factor

Behavioral test main outcome measures [3]from 16 to 20 months

number of premature responses

Brain MRI scan measuresfrom 16 to 20 months

whole brain structural connectivity, whole brain functional connectivity, brain cortical and subcortical structures volumes and morphology

Behavioral test main outcome measures [1]from 16 to 20 months

reaction times

Transcranial magnetic stimulationfrom 16 to 20 months

intracortical inhibition (SICI) scores

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath